4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients

Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients

Study Description
Brief Summary:
Noise in the ICU can worsen patient outcomes through factors such as increased cardiovascular stress, alteration in sleep, and increased discomfort or pain The purpose of this study is to determine the benefit of therapeutic music in the ICU on patients, their families, and ICU staff.

Condition or disease Intervention/treatment Phase
Anxiety Pain Critical Illness Relaxation Behavioral: Therapeutic Music Session Not Applicable

Detailed Description:
Noise in the ICU can worsen patient outcomes through factors such as increased cardiovascular stress, alteration in sleep, and increased discomfort or pain. The purpose of this study is to determine the benefit of therapeutic music in the ICU on patients, their families, and ICU staff. The results of this study will inform clinicians on best practices for redesigning, implementing and evaluating a patient and family focused therapeutic music program in the ICU.
Study Design
Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 300 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients: A Pilot, Prospective, Single-center Study of Therapeutic Music
Estimated Study Start Date : July 1, 2021
Estimated Primary Completion Date : December 2023
Estimated Study Completion Date : December 2023
Arms and Interventions
Arm Intervention/treatment
Experimental: Therapeutic Music Session Behavioral: Therapeutic Music Session
The 20 minute therapeutic music session will consist of classical music performed by a pianist with or without flute accompaniment with an individual patient's ICU room.

Outcome Measures
Primary Outcome Measures :
  1. Change in perceived pain visual analog score [ Time Frame: Immediately before and after therapeutic music session (about 20 minutes long) ]
    Comparison of patient reported perceived pain visual analog score using an 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst possible pain).

  2. Change in perceived anxiety visual analog score [ Time Frame: Immediately before and after therapeutic music session (about 20 minutes long) ]
    Comparison of patient reported perceived anxiety visual analog score using an 11-point numerical rating scale ranging from 0 (no anxiety) to 10 (worst possible anxiety).

  3. Change in perceived relaxation visual analog scale [ Time Frame: Immediately before and after therapeutic music session (about 20 minutes long) ]
    Comparison of patient reported perceived relaxation visual analog score using an 11-point numerical rating scale ranging from 0 (not relaxed at all) to 10 (completely relaxed).


Secondary Outcome Measures :
  1. Acceptability of Intervention Measure (AIM) [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Assessment of acceptability of therapeutic music session using the AIM which is a 4-item survey where each item is scored on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Higher total AIM scores indicate greater implementability. This assessment will be completed by patients, family members, and ICU clinical staff.

  2. Patient Perceived Impact [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Patient and family member perceived impact will be assessed using the Patient Music Evaluation Form. Patient and family member participants will complete this 2-item word choice question form to assess how live music made them feel (26 word choices offered eg., happy, sad, hopeful, energized) and whether the music performance made them do anything (20 word choices offered eg., laugh, smile, sing).

  3. Feasibility of Intervention (FIM) [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    ICU clinical staff perceived feasibility of therapeutic music session intervention will be assessed with the FIM, a 4-item, 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Higher total scores indicate greater feasibility.

  4. Intervention Appropriateness Measure (IAM) [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Assessment of appropriateness of therapeutic music session using the IAM which is a 4-item survey where each item is scored on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Higher total AIM scores indicate greater implementability. This assessment will be completed by ICU clinical staff.

  5. Perceived Barriers [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Perceived barriers will be assessed using qualitative analysis of a 2-item multiple response option and open-ended questions asking for feedback about facilitation and barriers to implementation of therapeutic music in ICU.


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Patient Inclusion Criteria:

  • Current hospitalization in adult ICU at Vanderbilt University Medical Center

Patient Exclusion Criteria:

  • Airborne or special contact isolation
  • Unstable hypotension or bradycardia
  • Pregnancy
  • Current prisoner status
  • The inability to communicate either verbally or in writing in English to complete the therapeutic music evaluations
  • Refusal to participate

Family Member Inclusion Criteria

  • Family member of ICU patient

Family Member Exclusion Criteria

  • The inability to communicate either verbally or in writing English to complete the therapeutic music evaluations
  • Refusal to participate

ICU Clinical Staff Inclusion Criteria

  • ICU clinical staff who are in the patient's room during the music session

ICU Clinical Staff Exclusion Criteria

  • Refusal to participate
Contacts and Locations

Contacts
Layout table for location contacts
Contact: Joseph J. Schlesinger, M.D. 615-343-6268 joseph.j.schlesinger@vumc.org
Contact: Gail Mayo 615-936-1705 gail.mayo@vumc.org

Locations
Layout table for location information
United States, Tennessee
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212
Sponsors and Collaborators
Vanderbilt University Medical Center
Investigators
Layout table for investigator information
Principal Investigator: Joseph J. Schlesinger Vanderbilt University Medical Center
Tracking Information
First Submitted Date  ICMJE May 6, 2019
First Posted Date  ICMJE May 14, 2019
Last Update Posted Date August 31, 2020
Estimated Study Start Date  ICMJE July 1, 2021
Estimated Primary Completion Date December 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: May 13, 2019)
  • Change in perceived pain visual analog score [ Time Frame: Immediately before and after therapeutic music session (about 20 minutes long) ]
    Comparison of patient reported perceived pain visual analog score using an 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst possible pain).
  • Change in perceived anxiety visual analog score [ Time Frame: Immediately before and after therapeutic music session (about 20 minutes long) ]
    Comparison of patient reported perceived anxiety visual analog score using an 11-point numerical rating scale ranging from 0 (no anxiety) to 10 (worst possible anxiety).
  • Change in perceived relaxation visual analog scale [ Time Frame: Immediately before and after therapeutic music session (about 20 minutes long) ]
    Comparison of patient reported perceived relaxation visual analog score using an 11-point numerical rating scale ranging from 0 (not relaxed at all) to 10 (completely relaxed).
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE
 (submitted: May 13, 2019)
  • Acceptability of Intervention Measure (AIM) [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Assessment of acceptability of therapeutic music session using the AIM which is a 4-item survey where each item is scored on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Higher total AIM scores indicate greater implementability. This assessment will be completed by patients, family members, and ICU clinical staff.
  • Patient Perceived Impact [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Patient and family member perceived impact will be assessed using the Patient Music Evaluation Form. Patient and family member participants will complete this 2-item word choice question form to assess how live music made them feel (26 word choices offered eg., happy, sad, hopeful, energized) and whether the music performance made them do anything (20 word choices offered eg., laugh, smile, sing).
  • Feasibility of Intervention (FIM) [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    ICU clinical staff perceived feasibility of therapeutic music session intervention will be assessed with the FIM, a 4-item, 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Higher total scores indicate greater feasibility.
  • Intervention Appropriateness Measure (IAM) [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Assessment of appropriateness of therapeutic music session using the IAM which is a 4-item survey where each item is scored on a 5-point Likert scale ranging from 1 (completely disagree) to 5 (completely agree). Higher total AIM scores indicate greater implementability. This assessment will be completed by ICU clinical staff.
  • Perceived Barriers [ Time Frame: After conclusion of therapeutic music session (about 20 minutes) ]
    Perceived barriers will be assessed using qualitative analysis of a 2-item multiple response option and open-ended questions asking for feedback about facilitation and barriers to implementation of therapeutic music in ICU.
Original Secondary Outcome Measures  ICMJE Same as current
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients
Official Title  ICMJE Assessing the Impact of LIve Music in the Intensive Care Unit (ICU) to Improve Care for Critically Ill Patients: A Pilot, Prospective, Single-center Study of Therapeutic Music
Brief Summary Noise in the ICU can worsen patient outcomes through factors such as increased cardiovascular stress, alteration in sleep, and increased discomfort or pain The purpose of this study is to determine the benefit of therapeutic music in the ICU on patients, their families, and ICU staff.
Detailed Description Noise in the ICU can worsen patient outcomes through factors such as increased cardiovascular stress, alteration in sleep, and increased discomfort or pain. The purpose of this study is to determine the benefit of therapeutic music in the ICU on patients, their families, and ICU staff. The results of this study will inform clinicians on best practices for redesigning, implementing and evaluating a patient and family focused therapeutic music program in the ICU.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Condition  ICMJE
  • Anxiety
  • Pain
  • Critical Illness
  • Relaxation
Intervention  ICMJE Behavioral: Therapeutic Music Session
The 20 minute therapeutic music session will consist of classical music performed by a pianist with or without flute accompaniment with an individual patient's ICU room.
Study Arms  ICMJE Experimental: Therapeutic Music Session
Intervention: Behavioral: Therapeutic Music Session
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Not yet recruiting
Estimated Enrollment  ICMJE
 (submitted: May 13, 2019)
300
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE December 2023
Estimated Primary Completion Date December 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Patient Inclusion Criteria:

  • Current hospitalization in adult ICU at Vanderbilt University Medical Center

Patient Exclusion Criteria:

  • Airborne or special contact isolation
  • Unstable hypotension or bradycardia
  • Pregnancy
  • Current prisoner status
  • The inability to communicate either verbally or in writing in English to complete the therapeutic music evaluations
  • Refusal to participate

Family Member Inclusion Criteria

  • Family member of ICU patient

Family Member Exclusion Criteria

  • The inability to communicate either verbally or in writing English to complete the therapeutic music evaluations
  • Refusal to participate

ICU Clinical Staff Inclusion Criteria

  • ICU clinical staff who are in the patient's room during the music session

ICU Clinical Staff Exclusion Criteria

  • Refusal to participate
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE
Contact: Joseph J. Schlesinger, M.D. 615-343-6268 joseph.j.schlesinger@vumc.org
Contact: Gail Mayo 615-936-1705 gail.mayo@vumc.org
Listed Location Countries  ICMJE United States
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT03948984
Other Study ID Numbers  ICMJE 190812
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Responsible Party Joseph Schlesinger, Vanderbilt University Medical Center
Study Sponsor  ICMJE Vanderbilt University Medical Center
Collaborators  ICMJE Not Provided
Investigators  ICMJE
Principal Investigator: Joseph J. Schlesinger Vanderbilt University Medical Center
PRS Account Vanderbilt University Medical Center
Verification Date August 2020

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP